Latest filing published 19 Aug 2024 for YIELD10 BIOSCIENCE, INC., €2,000. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Oliver P. Peoples is a declared insider of Yield10 Bioscience, Inc. (chief executive), with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 1 September 2021 and the latest from 15 August 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 19 August 2024 came the latest disclosure, a share grant for €2,000 in Yield10 Bioscience, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations